YouTube
Instagram
LinkedIn
Facebook

Advancing Gut Health Research Through European Collaboration – INTERCEPT Joins miGut-Health Final Conference

The miGut-Health final conference, Advancing Gut Health Research Through European Collaboration, will take place on 30 November 2026 at the Lithuanian Academy of Sciences in Vilnius. Participants will also be able to join online.

Researchers and external experts, including representatives from related European research projects such as INTERCEPT, ImmUniverse, PerPrev-CID, GlycanTrigger and DARKMATTER, will come together to discuss emerging biomarkers, microbiome restoration, dietary prevention and personalised approaches to inflammatory bowel disease (IBD).

INTERCEPT will be represented by Jonas Halfvarson from Örebro University, who will speak about biomarkers and disease prediction. The programme also features Junko F. Stevens of Thermo Fisher Scientific, Prof. Juozas Kupčinskas of LSMU, Prof. Dr Bahtiyar Yilmaz of the University of Bern, and Nicolas Benech of Lyon 1 and Hospices Civils de Lyon. Sessions will explore early disease prediction, mucosal mechanisms, microbial triggers, immune signatures, and the use of multi-omics and AI in precision medicine.

The programme continues on 1 December with a Health-Engagement Open Lab for people living with IBD in Lithuania, organised by the International Federation of Crohn’s and Colitis Associations (IFCCA).

To learn more and register, click here.